Omid (OMID, $0.02) was a top loser over the last three months, falling -1 to $0.02 per share. A.I.dvisor analyzed 205 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending June 4, 2025, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.